arrow
A

André Baruchel

assistance publique hopitaux paris
H指数:76
被引数:2.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Tisagenlecleucel for post-transplant relapse in young acute lymphoblastic leukemia patients: European real-world determinants of outcome
Leukemia
IF13.4
2026-08-310
OA
Identification of predictive factors for reversal of cerebral vasculopathy in an original longitudinal cohort study in newborns with sickle cell anaemia

对镰状细胞贫血新生儿中脑血管病变逆转的预测因素进行识别的原创性纵向队列研究

2026-08-210
OAAI
Long-term complications after total body irradiation in children younger than 4 years transplanted for acute lymphoblastic leukemia

小于4岁因急性淋巴细胞白血病接受全身照射的儿童长期并发症

2026-08-200
PRE
Characteristics and outcome determinants in children, adolescents and young adults who failed tisagenlecleucel for B-cell acute lymphoblastic leukemia

tisagenlecleucel治疗失败后,儿童、青少年和年轻成人B细胞急性淋巴细胞白血病的特征与结局决定因素

Leukemia
IF13.4
2026-02-240
PRE
TLX1 translocation variants and enhancer hijacking influence clinical outcome in T-cell acute lymphoblastic leukemia
2025-12-280
OAAI
Harmonization on defining B-cell recovery post CD19-CAR T-cell therapy in B-cell acute lymphoblastic leukemia: An international consensus statement

关于CD19-CAR T细胞疗法后B细胞恢复定义的标准化:一项国际共识声明

2025-11-120
OAAI
Hearing loss in French survivors of childhood and adolescent leukemia: impact on quality of life and schooling difficulties

法国儿童及青少年白血病幸存者的听力损失:对生活质量及学业困难的影响

2025-11-010
PRE
Isatuximab in combination with chemotherapy for pediatric patients with relapsed/refractory acute lymphoblastic leukemia or acute myeloid leukemia: The ISAKIDS study

Isatuximab联合化疗用于复发/难治性急性淋巴细胞白血病或急性髓系白血病的儿科患者:ISAKIDS研究

2025-10-300
OAAI
The watch-and-wait approach for patients with juvenile myelomonocytic leukemia: results of the French cohort

对于儿童骨髓单核细胞白血病患者采取的观察等待策略:法国队列研究的结果

Blood
IF23.1
2025-09-220
PRE
LEF1 intragenic deletion induces a dominant-negative isoform and unveils a Wnt/β3-catenin vulnerability in T-ALL

LEF1基因内缺失诱导产生显性负效异构体,并揭示T-ALL中Wnt/β3-连环蛋白的易损性。

Blood
IF23.1
2025-08-280
PRE
Towards methylation-based redefinition of TAL1 positive T-cell acute lymphoblastic leukaemia (T-ALL)

基于甲基化对TAL1阳性T细胞急性淋巴细胞白血病(T-ALL)的重新定义

Leukemia
IF13.4
2025-08-080
PRE
Evaluation of in vivo CAR transgene levels in tisagenlecleucel-treated patients with relapsed/refractory B-ALL and DLBCL

评估接受tisagenlecleucel治疗的复发/难治性B-ALL和DLBCL患者体内CAR转座子水平的评价

2025-06-260
OAAI
Phase 1/2 trial of anti-CD7 allogeneic WU-CART-007 for patients with relapsed/refractory T-cell malignancies

I 期/II 期临床试验:评估抗CD7 异基因 WU-CART-007 在复发/难治性 T 细胞恶性肿瘤患者中的疗效

Blood
IF23.1
2025-06-020
PRE